Publication | Closed Access
Enantioselective synthesis of S-1452, an orally active potent thromboxane A2 receptor antagonist
52
Citations
0
References
1991
Year
Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyChemistryPharmaceutical ChemistryPre-clinical PharmacologyMolecular PharmacologyMedicinal ChemistryTherapeutic Drug MonitoringSocial Media PresenceDrug DevelopmentNatural Product SynthesisPharmacologyEnantioselective SynthesisBiomolecular EngineeringDonut IconNatural SciencesFunctional SelectivityClinical PharmacologyMedicineDrug DiscoveryQuantitative Pharmacology
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTEnantioselective synthesis of S-1452, an orally active potent thromboxane A2 receptor antagonistMitsuaki Ohtani, Takaharu Matsuura, Fumihiko Watanabe, and Masayuki NarisadaCite this: J. Org. Chem. 1991, 56, 6, 2122–2127Publication Date (Print):March 1, 1991Publication History Published online1 May 2002Published inissue 1 March 1991https://pubs.acs.org/doi/10.1021/jo00006a030https://doi.org/10.1021/jo00006a030research-articleACS PublicationsRequest reuse permissionsArticle Views354Altmetric-Citations46LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts